Skip to content
Lower risk Medical device recall · FDA · Published September 4, 2019

Elekta Monaco RTP System 5.50/5.51: Incorrect Dose Calculation Risk

Elekta recalls Monaco RTP System software versions 5.50 and 5.51 due to potential incorrect radiation dose calculations, which could affect cancer treatment safety. Affected users should contact Elekta for details.

🇺🇸 FDA recall #Z-2561-2019Medical deviceElek: The Monaco RTP System ›
Take action

Contact the company

Recalling firmElekta Inc13723 Riverport Dr Ste 100 · Maryland Heights, MO 63043-4819
✎ GovInfoNow plain-language explainer

Elekta is recalling two software versions of its Monaco radiation treatment planning system because changes to electron density settings might cause incorrect dose calculations. This could lead to unsafe radiation treatment plans for cancer patients. Read more at govinfonow.com/recall/67071-elekta-monaco-rtp-system-5-50-5-51-incorrect-dose.

Source Summary by GovInfoNow · govinfonow.com/recall/67071-elekta-monaco-rtp-system-5-50-5-51-incorrect-dose · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2561-2019

Cite this page

“Elekta Monaco RTP System 5.50/5.51: Incorrect Dose Calculation Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/67071-elekta-monaco-rtp-system-5-50-5-51-incorrect-dose. Based on FDA recall #Z-2561-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2561-2019%22&limit=1).

The FDA announced on 2019-09-04 that Elekta, Inc. is voluntarily recalling the Monaco RTP System, versions 5.50 and 5.51, because forced electron density settings may change unintentionally, leading to incorrect dose calculations. The agency issued recall number Z-2561-2019 for the radiation treatment planning devices.

How to tell if you have it

  • Elekta Monaco RTP System, versions 5.50 and 5.51
  • UPC 00858164002244 (version 5.50)
  • UPC 00858164002268 (version 5.51)

The hazard

According to the FDA, the hazard is that forced electron density settings may be changed for some structures unintentionally, which can result in incorrect dose calculation.

Context

GovInfoNow's records show Elekta, Inc. has 39 other recalls on record since 2017-06-19. Recent Elekta recalls include the 2026-05-21 MOSAIQ Oncology System Software Recall for treatment plan loading risk, the 2026-04-03 Advanced Gynecological Applicator Recall for IU tube detachment risk, and the 2026-03-19 Leksell Vantage Arc System Recall for shifting coordinates risk. Other recent recalls of similar products include RayStation/RayPlan Software 11A Recalls (2025-11-28), RayStation Software Version 15.2.0/15.1.3 (2025-11-28), and RayStation/RayPlan 10B Software Recall (2025-11-28).

How to tell if you have this one

Check if you have the Monaco RTP System software versions 5.50 or 5.51. The system is used for radiation treatment planning in cancer care and has a unique identifier (UDI) starting with (01)00858164002244(10) for version 5.50.00.

  • Brand
    Elek: The Monaco RTP System
  • Product
    Elekta Inc recalls Monaco RTP System, 5.50/5.51, radiation treatment planning system
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide Distribution - US Nationwide in the states of WI, OH, NY, OH, IN, IA, TX, and countries of Canada, China, Denmark, Germany, Greece, Hong Kong, Italy, Netherlands, Sweden, UK
Recall numberProduct, codes & lotsQuantity
Z-2560-2019Monaco RTP System, 5.40 Unity, radiation treatment planning system Product Usage: The Monaco system is used to make treatment plans for patients with prescriptions for external beam radiation therapy. The system calculates dose for photon, electron, and carbon treatment plans and displays, on-screen and in hard-copy, two- or three-dimensional radiation dose distributions inside patients for given treatment plan set-ups. The Monaco product line is intended for use in radiation treatment planning. It uses generally accepted methods for: -contouring -image manipulation -simulation -image fusion -plan optimization -QA and plan review; UDI (01)00858164002190(10) 5.40.0030 units
Z-2561-2019Monaco RTP System, 5.50/5.51, radiation treatment planning system Product Usage: The Monaco system is used to make treatment plans for patients with prescriptions for external beam radiation therapy. The system calculates dose for photon, electron, and carbon treatment plans and displays, on-screen and in hard-copy, two- or three-dimensional radiation dose distributions inside patients for given treatment plan set-ups. The Monaco product line is intended for use in radiation treatment planning. It uses generally accepted methods for: -contouring -image manipulation -simulation -image fusion -plan optimization -QA and plan review; UDI: (01)00858164002244(10) 5.50.00 (01)00858164002268(10) 5.51.0049 units
Based on the official FDA remedy

What to do — step by step

  1. Contact Elekta

    Reach out to Elekta for specific guidance on the recalled software versions and next steps.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 6 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: named in the noticeWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: nationwideFL

FDA distribution: “Worldwide Distribution - US Nationwide in the states of WI, OH, NY, OH, IN, IA, TX, and countries of Canada, China, Denmark, Germany, Greece, Hong Kong, Italy, Netherlands, Sweden, UK” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Indiana, Iowa, New York, Ohio, Texas, Wisconsin.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: Sep 4, 201912. FDA classified it Class II: Sep 25, 201923. Published in FDA’s Enforcement Report: Oct 2, 201932019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

The recall is for potential incorrect dose calculations, which could affect cancer treatment safety. However, the hazard is not described as causing serious injury in normal use, so it's considered low risk.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2561-2019 (September 4, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2561-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA